| When it is available, will we take it? Public perception of hypothetical COVID-19 vaccine in Nigeria | Oral abstract session with live Q&A | Vaccines |
| Multi-stakeholder collaborative learning models to address COVID-19 in prisons and jails | E-poster | Non-pharmaceutical prevention |
| Ensuring continuity of services for key populations in the time of COVID-19 ' myth or reality? Adapting HIV prevention programs in the Islamic Republic of Iran in response to the epidemic | E-poster | Non-pharmaceutical prevention |
| SARS-CoV-2 viral shedding and COVID-19 symptoms in a prospective population-based cohort of newly-infected household members and healthcare workers | Oral abstract session with live Q&A | Non-pharmaceutical prevention |
| The prevention and control of COVID-19 epidemic in Mexico: it is urgent to change the government strategy | Oral abstract session with live Q&A | Global access and policy |
| Detrimental health effects of changes in cannabis use during the first COVID-19 lockdown among daily cannabis users in France: results from a national survey | E-poster | Global access and policy |
| Optimizing COVID-19 vaccine: can one-dose campaigns be better? | Oral abstract session with live Q&A | Vaccines |
| Utilising a multi-stakeholder consultation process to build NDoH's internal capacity to plan and implement national COVID-19 guidelines to ensure a phased resumption of VMMC services in South Africa | E-poster | Global access and policy |
| COVID-19 as a social disease: exploring prevention needs, impact and community responses to COVID-19 among ethnic minorities in Antwerp, Belgium | E-poster | Non-pharmaceutical prevention |
| Telehealth combined with differentiated ART delivery improves ART pick up during COVID-19 at a large HIV treatment facility in Trinidad and Tobago | E-poster | Non-pharmaceutical prevention |